Expert testimony plays a critical role in Patent Trial and Appeal Board (PTAB) proceedings at the U.S. Patent and Trademark Office (USPTO).

Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...

On February 12, 2025, the United States District Court for the District of Delaware denied defendant Parse Biosciences’s (“Parse”) motions for ...

A recent Nintendo patent hints that Switch 2 could include a major upgrade over its predecessor. And this could be big for ...

A new patent suggests that Nintendo Switch 2 will see a big improvement to voice chat, abandoning the current mobile app ...